Clinical Trials in Los Angeles

Showing 12241-12260 of 14,465 trials

Valproic Acid in Treating Patients With Kaposi's Sarcoma

NCT00075777

RATIONALE: Valproic acid may help stop the growth of Kaposi's sarcoma cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: This clinical trial is studying valproic acid in treating patients with HIV-related Kaposi's sarcoma.

Sarcoma

AIDS Malignancy Consortium19 participantsStarted Feb 2005

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +10 more locations

COMPLETEDPhase 1/2< 1 mile

Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer

NCT00323882

Multicenter study in which patients with metastatic hormone refractory prostate cancer (HRPC), who have not had previous chemotherapy or immunotherapy treatments, received MDX-010 every 3 weeks for 4 doses (12 weeks total duration of induction). MDX-010 was administered at escalating dosage levels of 3, 5, and 10 mg/kg/dose infusions. At least 6 patients were to be enrolled in each dosage level. Patients who tolerated and responded to treatment or who had stable disease for 3 months or longer and who subsequently progressed during the follow up phase of the study had the option to receive additional treatment with MDX-010, up to 4 cycles. Patients were followed in the study for response up to 2 years and were followed for survival status for up to 5 years after enrollment.

Prostate CancerNeoplasm Metastasis

Bristol-Myers Squibb75 participantsStarted Jan 2006

Los Angeles, California, United States • Los Angeles, California, United States • San Francisco, California, United States +11 more locations

Valproic Acid in Treating Patients With Kaposi's Sarcoma

Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer

Find Trials by Condition in Los Angeles

Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)

Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification

GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma

Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment

Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids

Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose

Home Telerehabilitation for Deconditioned Older Adults

A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus

Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis

A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)

A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene